Is There an Increased Negative Outcome for Hepatic Resection following Pre-operative Chemotherapy?

Espat, N. Joseph
February 2007
World Journal of Surgery;Feb2007, Vol. 31 Issue 2, p365
Academic Journal
The article reflects on the study regarding the evaluation of hospital and long term clinical outcomes for patients under neoadjuvant chemotherapy after hepatic resection. A standard procedure for colorectal hepatic metastases has conformed to the use of oxalipatin and observations on its outcome has also been conducted. Key information significant differences between data points are also discussed.


Related Articles

  • Pathologic response predicted survival after preoperative chemotherapy, resection of colorectal liver metastases.  // Hem/Onc Today;11/25/2008, Vol. 9 Issue 21, p25 

    This article focuses on a study which revealed that pathologic response and surgical margin status were independent predictors of survival after preoperative chemotherapy and resection of colorectal liver metastases, conducted by the University of Texas M. D. Anderson Cancer Center. An overview...

  • Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Gillams, A. R.; Lees, W. R. // European Radiology;May2009, Vol. 19 Issue 5, p1206 

    There is little published long-term survival data for patients with colorectal liver metastases treated with radiofrequency ablation (RFA). We present a multivariate analysis of 5-year survival in 309 patients (198 male, aged 64 (24–92)) treated at 617 sessions. Our standard protocol used...

  • Extended liver resection after preoperative chemotherapy: influence on regeneration and endoplasmic reticulum stress response. Manekeller, Steffen; Seinsche, Alexandra; Sioutis, Maria; Hirner, Andreas // Langenbeck's Archives of Surgery;Sep2009, Vol. 394 Issue 4, p681 

    The increasing interest in preoperative chemotherapy (CH) of liver metastasis after colorectal carcinoma has focused surgical concerns on the influence of CH on hepatic tolerance during intraoperative ischemia. In this context, CH was described to lead to massive parenchyma harm but also to...

  • Debunking Dogma: Surgery for Four or More Colorectal Liver Metastases Is Justified Pawlik, Timothy M.; Abdalla, Eddie K.; Ellis, Lee M.; Vauthey, Jean-Nicolas; Curley, Steven A. // Journal of Gastrointestinal Surgery;Feb2006, Vol. 10 Issue 2, p240 

    Treatment of four or more colorectal liver metastases (CRLMs) is controversial and remains a relative contraindication to surgery at some institutions. We sought to assess the outcome of patients with four or more CRLMs treated with surgery. Patients (159) with four or more CRLMs were treated...

  • Interventionelle Verfahren bei Lebermetastasen. Helmberger, T. // Der Chirurg;Jun2010, Vol. 81 Issue 6, p542 

    The therapeutic concept for hepatic metastases is mainly based on surgical resection and systemic chemotherapy. Considering technical respectability, oncological significance and limiting comorbidities, only 10–30% of patients with hepatic metastases can undergo surgery with a curative...

  • Disappearing colorectal liver metastases after chemotherapy: should we be concerned? Van Vledder, Mark G.; De Jong, Mechteld C.; Pawlik, Timothy M.; Schulick, Richard D.; Diaz, Luis A.; Choti, Michael A. // Journal of Gastrointestinal Surgery;Nov2010, Vol. 14 Issue 11, p1691 

    Background: With increasing efficacy of preoperative chemotherapy for colorectal cancer, more patients will present with one or more disappearing liver metastases (DLM) on preoperative cross-sectional imaging.Patients and Methods: A retrospective review was conducted...

  • Long-term survival of a patient with metachronous rectal metastasis from primary cecal cancer who underwent repetitive resection and chemotherapy: a case report. Jiro Shimazaki; Takeshi Nakachi; Takanobu Tabuchi; Hideyuki Ubukata; Takafumi Tabuchi // World Journal of Surgical Oncology;2014, Vol. 12 Issue 1, p1 

    There are few reported cases of colorectal metastasis from cancers of other organs, particularly other segments of the colon. Here we describe the long-term survival of a 68- year-old male patient with metachronous rectal metastasis from cecal cancer who underwent repetitive resection and...

  • Economic implications of hepatic arterial infusion chemotherapy in treatment of nonresectable... Durand-Zaleski, Isabelle; Roche, Beatrice // JNCI: Journal of the National Cancer Institute;06/04/97, Vol. 89 Issue 11, p790 

    Examines the economic implications of hepatic arterial infusion chemotherapy in the treatment of nonresectable colorectal liver metastases. Comparison of hepatic arterial infusion and intravenous chemotherapy; Health-care costs; Mean gain in life expectancy from hepatic arterial infusion.

  • Intra-arterial hepatic chemotherapy for liver malignancy. Malik, S.T.A.; Wrigley, P.F.M. // BMJ: British Medical Journal (International Edition);8/13/88, Vol. 297 Issue 6646, p434 

    Examines the intra-arterial hepatic chemotherapy for liver malignancy. Non-randomized studies of intra-arterial hepatic chemotherapy in primary and secondary liver cancer; Comparison of systemic and intra-arterial fluorouracil in patients with liver metastases of colorectal carcinoma; Decrease...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics